Clinical Trials in Dallas

Showing 9721-9740 of 17,468 trials

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

NCT03619837

In this study, subjects that do not have Hepatitis C virus (HCV) will be transplanted with livers or kidneys from donors who do have HCV. Medications that are used to treat HCV will be given to the study subjects shortly after transplant to protect them from developing the problems HCV can cause to the liver.

Hepatitis CTransplantation Disease Transmission

University of California, San Francisco122 participantsStarted Jul 2018

San Francisco, California, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +3 more locations

COMPLETEDPhase 4< 1 mile

Lurasidone Effects on Tissue Glutamate in Schizophrenia

NCT02199743

24 individuals with schizophrenia or schizoaffective disorders, who are currently considered stable, will be recruited, screened for entry criteria into a blinded study with a 4-week randomization to either lurasidone, haloperidol, or perphenazine to examine glutamate-related outcomes with lurasidone as compared to haloperidol and perphenazine.

SchizophreniaSchizoaffective Disorder

University of Texas Southwestern Medical Center35 participantsStarted Feb 2013

Dallas, Texas, United States

TERMINATEDPhase 2< 1 mile

Efficacy and Safety of Atacicept in IgA Nephropathy

NCT02808429

This main purpose of this study was to evaluate the safety, tolerability, dose response and efficacy of Atacicept in participants with IgA nephropathy and persistent proteinuria. The study hypothesis was that treatment with Atacicept would reduce proteinuria compared to placebo.

IgA Nephropathy

EMD Serono Research & Development Institute, Inc.16 participantsStarted Jan 2017

Glendale, Arizona, United States • Chula Vista, California, United States • Denver, Colorado, United States +15 more locations

Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant

Lurasidone Effects on Tissue Glutamate in Schizophrenia

Efficacy and Safety of Atacicept in IgA Nephropathy

Find Trials by Condition in Dallas

Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)

Celebrex In Acute Gouty Arthritis Study

A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

A Study Investigating the Effectiveness of a LifeSeasons NeuroQ Supplement With Lifestyle Changes to Improve Cognitive Function in Healthy Adults Who Have One or More Risk Factors for Cognitive Decline

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma

Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

A Sub-study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

Safety and Tolerability of PNT001 in Healthy Adults

NAPLS Omega-3 Fatty Acid Versus Placebo Study

Atorvastatin Three Year Pediatric Study

Hemodialysis Access Surveillance Evaluation Study